BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9183374)

  • 1. [Necrotizing myelopathy after intrathecal methotrexate].
    Sanhes L; Delmer A; Zittoun R
    Presse Med; 1997 May 3-10; 26(15):719. PubMed ID: 9183374
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 3. Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord.
    Gosavi T; Diong CP; Lim SH
    J Clin Neurosci; 2013 Jul; 20(7):1025-6. PubMed ID: 23647709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascending myelopathy after intrathecal methotrexate.
    Chiu YH; Yang E; Chen YC
    Kaohsiung J Med Sci; 2021 Nov; 37(11):1018-1019. PubMed ID: 34292665
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate myelopathy after intrathecal chemotherapy: a case report.
    Murata KY; Maeba A; Yamanegi M; Nakanishi I; Ito H
    J Med Case Rep; 2015 Jun; 9():135. PubMed ID: 26055509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
    Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K
    J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dorsal column myelopathy after intrathecal chemotherapy for leukemia.
    Pinnix CC; Chi L; Jabbour EJ; Milgrom SA; Smith GL; Daver N; Garg N; Cykowski MD; Fuller G; Cachia D; Kamiya-Matsuoka C; Woodman K; Dinardo C; Jain N; Kadia TM; Pemmaraju N; Ohanian M; Konopleva M; Kantarjian HM; Dabaja BS
    Am J Hematol; 2017 Feb; 92(2):155-160. PubMed ID: 27874212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma.
    Elkiran ET; Altundag K; Aksoy S; Onal IK; Tekuzman G
    Am J Hematol; 2004 Apr; 75(4):265. PubMed ID: 15054831
    [No Abstract]   [Full Text] [Related]  

  • 9. MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk.
    Juster-Switlyk K; Smith AG; Kovacsovics T; Stephens D; Glenn M; Palmer CA; Quigley EP; Kolb N
    Neurology; 2017 Feb; 88(6):603-604. PubMed ID: 28062724
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrathecal methotrexate-induced acute chorea.
    Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Treatment of accidental intrathecal methotrexate overdose.
    Gosselin S; Isbister GK
    J Natl Cancer Inst; 2005 Apr; 97(8):609-10; author reply 610-1. PubMed ID: 15840887
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathecal methotrexate-induced acute cerebellar syndrome.
    Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
    Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.
    Strunk T; Gottschalk S; Goepel W; Bucsky P; Schultz C
    Med Pediatr Oncol; 2003 Jan; 40(1):48-50. PubMed ID: 12426687
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracerebral hematoma as a complication of intrathecal methotrexate administration.
    Boran P; Tokuc G; Boran BO; Oktem S
    Pediatr Blood Cancer; 2008 Jan; 50(1):152-4. PubMed ID: 16615061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral subdural hygromas following intrathecal methotrexate.
    Lokireddy P; Dyer MJ
    Br J Haematol; 2011 Dec; 155(5):536. PubMed ID: 21923656
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute tumor lysis syndrome following intrathecal methotrexate.
    Benekli M; Güllü IH; Savaş MC; Kadayifçi A; Altundağ MK; Tekuzman G; Firat D
    Leuk Lymphoma; 1996 Jul; 22(3-4):361-3. PubMed ID: 8819088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior reversible encephalopathy after intrathecal methotrexate therapy in diffuse large B-cell lymphoma.
    Patel A; Ayto R; MacDonald DH
    Br J Haematol; 2013 Jun; 161(5):607. PubMed ID: 23617825
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent hyponatremia after intrathecal methotrexate not related to antidiuretic hormone: is a natriuretic peptide activated?
    Diskin C; Dansby LM; Radcliff L; Carter TB; Graves E; Graves A
    Am J Med Sci; 2006 Jan; 331(1):37-9. PubMed ID: 16415663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disseminated necrotizing leukoencephalopathy].
    Araga S
    Nihon Rinsho; 2004 Jan; 62 Suppl():312-4. PubMed ID: 15011373
    [No Abstract]   [Full Text] [Related]  

  • 20. Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization.
    Caldeira T; Costa V; Silva I; Oliva T; Norton L
    Pediatr Hematol Oncol; 2008 Mar; 25(2):131-4. PubMed ID: 18363180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.